Opendata, web and dolomites

HEcoPerMed SIGNED

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "HEcoPerMed" data sheet

The following table provides information about the project.

Coordinator
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH 

Organization address
address: GIEFINGGASSE 4
city: WIEN
postcode: 1210
website: http://www.ait.ac.at/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 1˙998˙437 €
 EC max contribution 1˙998˙437 € (100%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH AT (WIEN) coordinator 312˙500.00
2    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) participant 700˙937.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 383˙750.00
4    INSTITUTE FOR MEDICAL TECHNOLOGY ASSESSMENT BV NL (ROTTERDAM) participant 376˙250.00
5    SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG HU (BUDAPEST) participant 225˙000.00

Map

 Project objective

HEcoPerMed responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine and seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the requirements of personalised medicine for more compre-hensive cost-effectiveness estimates that incorporate patient and societal perspectives and enhance sustainable affordability of cutting-edge health innovations. HEcoPerMed will provide an overview of and guidance on high-quality methodological approaches for model-based economic evaluations. In three case studies, HEcoPerMedwill apply state-of-the art economic modelling to demonstrate practical and methodological issues in evaluating personalised medicine innovations. The project team will also study existing shortcomings in stimulating the adoption of personalised medicine and pro-pose financial agreements that accelerate its diffusion in European health systems. HEcoPerMed will construct future scenarios, considering the trends and drivers as well as challenges and benefits of personalised medicine for the European social model of care and its financial viability. For a better financial integration of personalised medicine and new economic models, the project team will develop appropriate diffusion and communication strategies to be in direct contact with experts and a wide variety of stakeholders, taking their needs into account while offering new solutions for the players within the European health systems. These comprehensive measures will fill a gap identified by the ICPerMed to support their efforts in the promotion of personalised medicine in Europe and beyond. The project will support health care decision makers to manage their budgets while providing the best possible care for patients in the field of personalised medicine.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HECOPERMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HECOPERMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

PERMIT (2020)

PERsonalised MedicIne Trials

Read More  

SINO-EU-PerMed (2020)

Widening Sino‐EU policy and research cooperation in Personalised Medicine

Read More  

EBRA (2018)

European Brain Research Area

Read More